日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cisplatin during radiation for head and neck cancer: insights from NRG Oncology experience

头颈癌放疗期间使用顺铂:NRG肿瘤学的经验启示

Sousa, Luana G; Edward Bates, James; Anand, Payal; Caudell, Jimmy J; Colevas, A Dimitrios; Runge, Christina L; Sharon, Jeffrey D; Awan, Musaddiq; Beadle, Beth M; Choe, Jennifer H; Gidley, Paul W; Harari, Paul M; Henson, Christina; Katzel, Jed A; Lee, Nancy Y; McDowell, Lachlan; Mell, Loren K; Nader, Marc-Elie; Rudra, Soumon; Wang, Kaiwen; Yang, George; Yom, Sue S; Wise-Draper, Trisha M

Cardiac Troponin Screening and Clinical Outcomes in Patients Receiving Immunotherapy

接受免疫治疗患者的心肌肌钙蛋白筛查和临床结果

Cheng, Evaline; Ivanovic, Maja; Chan, Antonia; Xu, Sidra; Franquiz, Miguel; Lee, Carissa; You, Jonathan; Fazal, Muhammad; Le Guen, Yann; Batchelder, Ryan; Reddy, Sunil A; Katsumoto, Tamiko; Ramchandran, Kavitha; Colevas, A Dimitrios; Kahn, Saad; Fan, Alice; Wakelee, Heather; Cheng, Paul; Lewis, Eldrin F; Wu, Sean M; Witteles, Ronald; Neal, Joel; Waliany, Sarah; Zhu, Han

First-in-Human Clinical Trial of a Small-Molecule EBNA1 Inhibitor, VK-2019, in Patients with Epstein-Barr-Positive Nasopharyngeal Cancer, with Pharmacokinetic and Pharmacodynamic Studies.

首次对 Epstein-Barr 阳性鼻咽癌患者进行小分子 EBNA1 抑制剂 VK-2019 的人体临床试验,并进行药代动力学和药效学研究

Colevas A Dimitrios, Talebi Zahra, Winters Elizabeth, Even Caroline, Lee Victor Ho-Fun, Gillison Maura L, Khan Saad A, Lu Rong, Pinsky Benjamin A, Soldan Samantha S, Vladmirova Olga, Lieberman Paul M, Messick Troy E

Cost of Neoadjuvant Immunotherapy vs Up-Front Surgery in Cutaneous Squamous Cell Carcinoma: A Post Hoc Analysis of a Nonrandomized Clinical Trial

皮肤鳞状细胞癌新辅助免疫疗法与直接手术治疗的成本比较:一项非随机临床试验的事后分析

Wu, Shannon S; Colevas, A Dimitrios; Martinez Ramirez, Luis; Megwalu, Uchechukwu C; Chen, Michelle M; Atwell, Aronpreet; Divi, Vasu

Update: Immunotherapeutic Strategies in HPV-Associated Head and Neck Squamous Cell Carcinoma

最新进展:HPV相关头颈部鳞状细胞癌的免疫治疗策略

Sun, Fangdi; Colevas, A Dimitrios

Ninth Version of the AJCC and UICC Nasopharyngeal Cancer TNM Staging Classification

美国癌症联合委员会和国际抗癌联盟鼻咽癌分期分类第九版

Pan, Jian-Ji; Mai, Hai-Qiang; Ng, Wai Tong; Hu, Chao-Su; Li, Jin-Gao; Chen, Xiao-Zhong; Chow, James C H; Wong, Edwin; Lee, Victor; Ma, Ling-Yu; Guo, Qiao-Juan; Liu, Qin; Liu, Li-Zhi; Xu, Ting-Ting; Gong, Xiao-Chang; Qiang, Meng-Yun; Au, Kwok-Hung; Liu, Tsz-Chim; Chiang, Chi Leung; Xiao, You-Ping; Lin, Shao-Jun; Chen, Yun-Bin; Guo, Shan-Shan; Wong, Charlene H L; Tang, Lin-Quan; Xu, Zhi-Yuan; Jia, Yi-Zhen; Peng, Wen-Sa; Hu, Li-Ping; Lu, Tian-Zhu; Jiang, Feng; Cao, Cai-Neng; Xu, Wei; Ma, Jun; Blanchard, Pierre; Williams, Michelle; Glastonbury, Christine M; King, Ann D; Patel, Snehal G; Seethala, Raja R; Colevas, A Dimitrios; Fan, Dai-Ming; Chua, Melvin L K; Huang, Shao Hui; O'Sullivan, Brian; Lydiatt, William; Lee, Anne W M

Multicenter validation of an RNA-based assay to predict anti-PD-1 disease control in patients with recurrent or metastatic head and neck squamous cell carcinoma: the PREDAPT study

一项基于RNA的检测方法在预测复发或转移性头颈部鳞状细胞癌患者抗PD-1疾病控制方面的多中心验证:PREDAPT研究

Flanagan, Kevin C; Earls, Jon; Hiken, Jeffrey; Wellinghoff, Rachel L; Ponder, Michelle M; McLeod, Howard L; Westra, William H; Vavinskaya, Vera; Sutton, Leisa; Deichaite, Ida; Macdonald, Orlan K; Welaya, Karim; Wade, James 3rd; Azzi, Georges; Pippas, Andrew W; Slim, Jennifer; Bank, Bruce; Sui, Xingwei; Kossman, Steven E; Shenkenberg, Todd D; Alexander, Warren L; Price, Katharine A; Ley, Jessica; Messina, David N; Glasscock, Jarret I; Colevas, A Dimitrios; Cohen, Ezra E W; Adkins, Douglas; Duncavage, Eric J

Long-term Outcomes of Bevacizumab and Chemoradiation for Locoregionally Advanced Nasopharyngeal Carcinoma: A Nonrandomized Controlled Trial

贝伐珠单抗联合放化疗治疗局部晚期鼻咽癌的长期疗效:一项非随机对照试验

Lee, Nancy Y; Harris, Jonathan; Kim, John; Garden, Adam; Mechalakos, James; Pfister, David G; Chan, Anthony T C; Hu, Kenneth; Colevas, A Dimitrios; Frank, Steven; Shenouda, George; Bar-Ad, Voichita; Waldron, John N; Harari, Paul M; Raben, Adam; Torres-Saavedra, Pedro; Le, Quynh-Thu

Safety of Nivolumab Added to Chemoradiation Therapy Platforms for Intermediate and High-Risk Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: RTOG Foundation 3504

纳武利尤单抗联合放化疗治疗中高危局部晚期头颈部鳞状细胞癌的安全性:RTOG基金会3504

Gillison, Maura L; Ferris, Robert L; Harris, Jonathan; Colevas, A Dimitrios; Mell, Loren K; Kong, Christina; Jordan, Richard C; Moore, Kevin L; Truong, Minh-Tam; Kirsch, Claudia; Chakravarti, Arnab; Blakaj, Dukagjin M; Clump, David A; Ohr, James P; Deeken, John F; Gensheimer, Michael F; Saba, Nabil F; Dorth, Jennifer A; Rosenthal, David I; Leidner, Rom S; Kimple, Randall J; Machtay, Mitchell; Curran, Walter J Jr; Torres-Saavedra, Pedro; Le, Quynh Thu

In search for optimal induction chemotherapy for advanced nasopharyngeal cancer: Standard dosing of Docetaxel, Platinum, and 5-Fluorouracil (TPF) followed by chemoradiation

寻找晚期鼻咽癌的最佳诱导化疗方案:多西他赛、铂类和5-氟尿嘧啶(TPF)标准剂量方案,随后进行放化疗

Jun, Michelle; Pinto, Harlan; Le, Quynh-Thu; Quon, Andrew; Hara, Wendy; Coty, Jessie; McMillan, Alex; Lu, Rong; Winters, Elzbieta; Lira, Ruth; Colevas, A Dimitrios